Literature DB >> 21317297

Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.

Youn-Tae Kwak1, Sofyan M Radaideh, Lianghao Ding, Rui Li, Eugene Frenkel, Michael D Story, Luc Girard, John Minna, Udit N Verma.   

Abstract

The catalytic subunits of IκB kinase (IKK) complex, IKKα and IKKβ, are involved in activation of NF-κB and in mediating a variety of other biological functions. Though these proteins have a high-sequence homology, IKKα exhibits different functional characteristics as compared with IKKβ. Earlier, we have shown that cyclin D1 is overexpressed and predominantly localized in the nucleus of IKKα(-/-) cells, indicating that IKKα regulates turnover and subcellular distribution of cyclin D1, which is mediated by IKKα-induced phosphorylation of cyclin D1. Because cyclin D nuclear localization is implicated in tumor development, we examined whether the absence of IKKα leads to tumor development as well. In the current study, we show that IKKα plays a critical role in tumorigenesis. Though IKKα(-/-) MEF cells show a slower anchorage-dependent growth, they are clonogenic in soft agar. These cells are tumorigenic in nude mice. Microarray analysis of IKKα(-/-) cells indicates a differential expression of genes involved in proliferation and apoptosis. Furthermore, analysis of microarray data of human lung cancer cell lines revealed decreased IKKα RNA expression level as compared with cell lines derived from normal bronchial epithelium. These results suggest that IKKα may function as a tumor suppressor gene. Absence of IKKα may induce tumorigenicity by nuclear localization of cyclin D1 and modulating the expression of genes involved in neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317297      PMCID: PMC3072035          DOI: 10.1158/1541-7786.MCR-10-0248

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  50 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

2.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

Authors:  J D Woronicz; X Gao; Z Cao; M Rothe; D V Goeddel
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

4.  Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer.

Authors:  C-H Chen; J Shen; W-J Lee; S-N Chow
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

5.  Normalization and subtraction: two approaches to facilitate gene discovery.

Authors:  M F Bonaldo; G Lennon; M B Soares
Journal:  Genome Res       Date:  1996-09       Impact factor: 9.043

6.  Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.

Authors:  N A Hibberts; D J Simpson; J E Bicknell; J C Broome; P R Hoban; R N Clayton; W E Farrell
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

7.  Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA, genomic structure, and expression.

Authors:  M Nagira; T Imai; I Ishikawa; K I Uwabe; O Yoshie
Journal:  Cell Immunol       Date:  1994-08       Impact factor: 4.868

8.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

9.  Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains.

Authors:  R N Tamura; H M Cooper; G Collo; V Quaranta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Characterization of a mouse mitogen-regulated protein/proliferin gene and its promoter: a member of the growth hormone/prolactin gene superfamily.

Authors:  A M Connor; P Waterhouse; R Khokha; D T Denhardt
Journal:  Biochim Biophys Acta       Date:  1989-09-21
View more
  9 in total

Review 1.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

2.  Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.

Authors:  Yumei Du; Guangyao Kong; Xiaona You; Shuai Zhang; Tao Zhang; Yuen Gao; Lihong Ye; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

Review 3.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

4.  The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

Authors:  Zuoxiang Xiao; Qun Jiang; Jami Willette-Brown; Sichuan Xi; Feng Zhu; Sandra Burkett; Timothy Back; Na-Young Song; Mahesh Datla; Zhonghe Sun; Romina Goldszmid; Fanching Lin; Travis Cohoon; Kristen Pike; Xiaolin Wu; David S Schrump; Kwok-Kin Wong; Howard A Young; Giorgio Trinchieri; Robert H Wiltrout; Yinling Hu
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

5.  Apigenin blocks IKKα activation and suppresses prostate cancer progression.

Authors:  Sanjeev Shukla; Rajnee Kanwal; Eswar Shankar; Manish Datt; Mark R Chance; Pingfu Fu; Gregory T MacLennan; Sanjay Gupta
Journal:  Oncotarget       Date:  2015-10-13

6.  Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.

Authors:  Eyra Marien; Michael Meister; Thomas Muley; Teresa Gomez Del Pulgar; Rita Derua; Jeffrey M Spraggins; Raf Van de Plas; Frank Vanderhoydonc; Jelle Machiels; Maria Mercedes Binda; Jonas Dehairs; Jami Willette-Brown; Yinling Hu; Hendrik Dienemann; Michael Thomas; Philipp A Schnabel; Richard M Caprioli; Juan Carlos Lacal; Etienne Waelkens; Johannes V Swinnen
Journal:  Oncotarget       Date:  2016-03-15

7.  Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.

Authors:  Inês Sequeira; Mamunur Rashid; Inês M Tomás; Marc J Williams; Trevor A Graham; David J Adams; Alessandra Vigilante; Fiona M Watt
Journal:  Nat Commun       Date:  2020-11-09       Impact factor: 14.919

8.  Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing.

Authors:  Weiwei Lai; Jiantao Jia; Bin Yan; Yiqun Jiang; Ying Shi; Ling Chen; Chao Mao; Xiaoli Liu; Haosheng Tang; Menghui Gao; Ya Cao; Shuang Liu; Yongguang Tao
Journal:  Oncotarget       Date:  2017-12-04

9.  Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.

Authors:  Shih-Chi Su; Chiao-Wen Lin; Yu-Fan Liu; Wen-Lang Fan; Mu-Kuan Chen; Chun-Ping Yu; Wei-En Yang; Chun-Wen Su; Chun-Yi Chuang; Wen-Hsiung Li; Wen-Hung Chung; Shun-Fa Yang
Journal:  Theranostics       Date:  2017-02-26       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.